Bum Soo Kim1, In Joo Kim2, Seong-Jang Kim3, Hyun-Yeol Nam1, Kyoung June Pak1, Keunyoung Kim1, Man Soo Yun4. 1. Department of Nuclear Medicine, Pusan National University School of Medicine, Busan, Republic of Korea. 2. Department of Nuclear Medicine, Pusan National University School of Medicine, Busan, Republic of Korea ; Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea ; Department of Nuclear Medicine, Pusan National University Hospital and Medical Research Institute, Pusan National University, Busan, Republic of Korea. 3. Department of Nuclear Medicine, Pusan National University School of Medicine, Busan, Republic of Korea ; Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea. 4. Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea ; Department of Gynecology and Oncology, Pusan National University School of Medicine, Busan, Republic of Korea.
Abstract
PURPOSE: The purpose of this study was to evaluate the prognostic value of the metabolic tumor volume (MTV), in FIGO stage IA-IIB cervical cancer patients, measured by F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. METHODS: Forty-five patients with invasive cervical cancer who underwent FDG-PET imaging were recruited. Metabolically active tumor regions were delineated on the pretreatment FDG-PET scans by encompassing regions equal to or greater than an standardized uptake value (SUV) of 40% of the peak tumor intensity. The relationship of the metabolic tumor volume (MTV) to the disease-free survival was analyzed. The MTV of the cervical cancer was compared with pathological and clinical prognostic factors, including lymph node metastasis, parametrial invasion, the depth of invasion, resection margins, tumor differentiation and FIGO stages. RESULTS: Cox proportional hazard regression analysis showed that the MTV was a significant independent predictor of recurrence of cervical cancer (p = 0.027). Patients with an MTV of >20 cm(3) had a significantly reduced disease-free survival compared with patients with an MTV ≤ 20 cm(3) (p = 0.029). The correlation of the MTV with traditional prognostic factors showed significantly higher values in patients that were lymph node (LN) metastasis positive (p = 0.028) and parametrial invasion positive (p = 0.022). The MTV significantly differed among the groups according to tumor differentiation (p = 0.0319) and FIGO stage (p = 0.001). CONCLUSION: The MTV measured by FDG-PET was an independent prognostic factor for tumor recurrence in patients with stage IA-IIB cervical cancer. These findings must be confirmed by large population based prospective studies.
PURPOSE: The purpose of this study was to evaluate the prognostic value of the metabolic tumor volume (MTV), in FIGO stage IA-IIB cervical cancerpatients, measured by F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. METHODS: Forty-five patients with invasive cervical cancer who underwent FDG-PET imaging were recruited. Metabolically active tumor regions were delineated on the pretreatment FDG-PET scans by encompassing regions equal to or greater than an standardized uptake value (SUV) of 40% of the peak tumor intensity. The relationship of the metabolic tumor volume (MTV) to the disease-free survival was analyzed. The MTV of the cervical cancer was compared with pathological and clinical prognostic factors, including lymph node metastasis, parametrial invasion, the depth of invasion, resection margins, tumor differentiation and FIGO stages. RESULTS: Cox proportional hazard regression analysis showed that the MTV was a significant independent predictor of recurrence of cervical cancer (p = 0.027). Patients with an MTV of >20 cm(3) had a significantly reduced disease-free survival compared with patients with an MTV ≤ 20 cm(3) (p = 0.029). The correlation of the MTV with traditional prognostic factors showed significantly higher values in patients that were lymph node (LN) metastasis positive (p = 0.028) and parametrial invasion positive (p = 0.022). The MTV significantly differed among the groups according to tumor differentiation (p = 0.0319) and FIGO stage (p = 0.001). CONCLUSION: The MTV measured by FDG-PET was an independent prognostic factor for tumor recurrence in patients with stage IA-IIB cervical cancer. These findings must be confirmed by large population based prospective studies.
Authors: George A Plataniotis; Maria-Ekaterini Theofanopoulou; Anna Kalogera-Fountzila; Afroditi Haritanti; Elisabeta Ciuleanou; Nicolae Ghilezan; Nikolaos Zamboglou; Athanasios Dimitriadis; Ioannis Sofroniadis; George Fountzilas Journal: Int J Radiat Oncol Biol Phys Date: 2004-07-15 Impact factor: 7.038
Authors: Michael Shapiro; Mijin Yun; Jacqueline M Junkins-Hopkins; Carmela C Vittorio; Norman Schulman; Bruce H Saidman; Richard G Fried; Alain H Rook; Abass Alavi Journal: J Am Acad Dermatol Date: 2002-10 Impact factor: 11.527
Authors: R D Alvarez; M E Potter; S J Soong; F L Gay; K D Hatch; E E Partridge; H M Shingleton Journal: Gynecol Oncol Date: 1991-11 Impact factor: 5.482
Authors: Young Mi Seol; Bo Ran Kwon; Moo Kon Song; Young Jin Choi; Ho Jin Shin; Joo Seop Chung; Goon Jae Cho; Jin Chun Lee; Byung Joo Lee; Soo Geun Wang; Hak Jin Kim; Won Taek Kim; Seung Jang Kim; Eun Young Yun Journal: Acta Oncol Date: 2010 Impact factor: 4.089
Authors: Hyun Jeong Kim; Jiyoun Choi; Yong Hyu Jeong; Kwan Hyeong Jo; Jae-Hoon Lee; Arthur Cho; Mijin Yun; Jong Doo Lee; Young Tae Kim; Won Jun Kang Journal: Nucl Med Mol Imaging Date: 2013-09-06